calendar
370 catalysts · 3,728 phase readout · 2,102 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
370 catalysts · 3,728 phase readout · 2,102 8k filing · 276 earnings · 172 phase 2 completion · 152 grant · 133 drug shortage
Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR
Supplement type: 30-Day Notice. Product code: MDP. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QZK. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MFE. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: MCM. Advisory committee: EN. Decision: OK30
Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: 30-Day Notice. Product code: MOZ. Advisory committee: OR. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: OAD. Advisory committee: CV. Decision: OK30
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MWG. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QZH. Advisory committee: TX. Decision: APPR
Supplement type: Real-Time Process. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NAW. Advisory committee: RA. Decision: APPR
Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30
Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30
Anticipated earnings call for ACME UNITED CORP ($ACU).
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Nutritional Disorders. Indication: Hyperphosphatemia
Therapy area: Metabolic Disorders. Indication: Obesity
Therapy area: Musculoskeletal Disorders. Indication: Bone Fracture
Therapy area: Dermatology. Indication: Wounds
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Central Nervous System. Indication: Pain
Therapy area: Hematological Disorders. Indication: Iron Deficiency Anemia
Therapy area: Hematological Disorders, Mouth and Dental Disorders. Indication: Dental Caries, Gingivitis, Hemorrhage, Periodontitis
Therapy area: Gastrointestinal. Indication: Liver Failure (Hepatic Insufficiency)
Therapy area: Mouth and Dental Disorders. Indication: Periodontitis
Therapy area: Women's Health. Indication: Unspecified Gynecological Disorders
Therapy area: Oncology. Indication: Follicular Thyroid Cancer, Papillary Thyroid Cancer, Thyroid Cancer
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Immunology. Indication: Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis
Therapy area: Central Nervous System. Indication: Anxiety Disorders
Therapy area: Genito Urinary System. Indication: Chronic Kidney Disease (Chronic Renal Failure)